Publicacións (16) Publicacións de Miguel Ángel Llaneza González

2023

  1. Best practices in phase III clinical trials on DMTs for multiple sclerosis: A systematic analysis and appraisal of published trials

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 95, Núm. 4, pp. 333-341

  2. Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study

    Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193

2022

  1. Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology

    Multiple Sclerosis and Related Disorders, Vol. 63

  2. Multiple plaques of morphea in a patient with multiple sclerosis treated with alemtuzumab

    Piel, Vol. 37, Núm. 10, pp. e70-e71

  3. Real life efficacy and tolerability of cladribine: multicentre study in galicia (CLADRIGAL)

    MULTIPLE SCLEROSIS JOURNAL, Vol. 28, Núm. Supl. 3, pp. 893-894

2021

  1. SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry

    Neurology(R) neuroimmunology & neuroinflammation, Vol. 8, Núm. 5

2016

  1. Fingolimod: Efectividad y seguridad en la práctica clínica habitual. Estudio observacional,retrospectivo y multicéntrico en Galicia

    Revista de Neurologia, Vol. 63, pp. S13-S18

2015

  1. Compliance of the guidelines of the Spanish Neurology Society in the treatment of patients with multiple sclerosis

    Revista de Neurologia, Vol. 61, Núm. 4, pp. 145-152

2014

  1. Efficacy and safety of Fingolimod in clinical practice

    MULTIPLE SCLEROSIS JOURNAL, Vol. 20, Núm. Supl 1, pp. 211

  2. Management of complications related to intraduodenal infusion of levodopa/carbidopa in patients with Parkinson's disease

    Revista de Neurologia, Vol. 58, Núm. 11, pp. 505-515

2012

  1. Long-term exposure to duodenal levodopa/carbidopa infusion therapy improves quality of life in relation especially to mobility, activities of daily living, and emotional well-being

    Acta Neurologica Scandinavica, Vol. 125, Núm. 3, pp. 187-191

2011

  1. Pain in Parkinsons disease: Prevalence, characteristics, associated factors, and relation with other non motor symptoms, quality of life, autonomy, and caregiver burden

    Revista de Neurologia, Vol. 52, Núm. 7, pp. 385-393

2010

  1. Duodenal levodopa infusion tube obstruction solved under real-time fluoroscopic X-ray imaging

    Revista de Neurologia, Vol. 50, Núm. 10, pp. 634-635

  2. Síntomas sensoriales en la enfermedad de Parkinson

    Revista de Neurologia, Vol. 50, Núm. SUPPL. 2

2009

  1. P2.158 Duodenal levodopa infusion improves motor symptoms and quality of life in advanced Parkinson disease: report of nine patients

    Parkinsonism & Related Disorders, Vol. 15, pp. S132

  2. Restless legs syndrome

    Revista de Neurologia, Vol. 48, Núm. SUPPL. 1